Evidence map›Paper›PMID 34885701›Full record

ArticleMolecules (Basel, Switzerland)2021

Synthesis, Identification, Computer-Aided Docking Studies, and ADMET Prediction of Novel Benzimidazo-1,2,3-triazole Based Molecules as Potential Antimicrobial Agents.

Huda R M Rashdan, Aboubakr H Abdelmonsef, Mortaga M Abou-Krisha, Tarek A Yousef

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. New 1,3-diphenyl-1Heliyon · 2024
    Article
  6. Article
  7. Review
  8. Design, synthetic approach,RSC advances · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Huda R M RashdanChemistry of Natural and Microbial Products Department, Pharmaceutical and Drug Industries Research Institute, National Research Institute, Dokki, Cairo 12622, Egypt.ORCID 0000-0001-7474-1678
Aboubakr H AbdelmonsefChemistry Department, Faculty of Science, South Valley University, Qena 83523, Egypt.ORCID 0000-0002-4616-0224
Mortaga M Abou-KrishaChemistry Department, Faculty of Science, South Valley University, Qena 83523, Egypt.ORCID 0000-0003-2224-8165
Tarek A YousefChemistry Department, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11623, Saudi Arabia.ORCID 0000-0003-3039-7646
South Valley University · EGImam Mohammad ibn Saud Islamic University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

2-azido-1

Indexed as

Anti-Infective AgentsAspergillus nigerBacterial InfectionsCandida albicansDNA GyraseEscherichia coliHumansMolecular Docking SimulationPharmacokineticsPseudomonas aeruginosaStaphylococcus aureusStructure-Activity RelationshipTopoisomerase II InhibitorsTriazolesAnti-Infective AgentsDNA GyraseTopoisomerase II InhibitorsTriazoles1,2,3-triazoles1,3,4-thiadiazoleantimicrobial activitybenzimidazoledocking study

Identifiers

PMID34885701
PMCPMC8659132
OpenAlexW3217596937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.